EZH2 and cancer: Previous studies have elucidated that enhancer of zeste homolog 2 (EZH2), a histone lysine methyltransferase, plays complex roles in tumorigenesis and cancer development by influencing various cellular processes, including cell cycle progression, autophagy, and apoptosis (Duan et al., 2020).